Brain Mets in HER2-Positive Cancer

Brain mets

Brain metastases

  • Major impact on morbidity and mortality
  • Treatment adaptation (HER2-targeted therapy, kinase inhibitors that cross the blood-brain barrier)+ follow-up, Stereotactic Radiosurgery Guidance, Recurrence Monitoring


  • Follow-up of patients diagnosed with brain metastases


  • Follow-up of brain metastases & detection of recurrence: difficult today

Our solution

Direct detection of HER2 positive cells throughout the body, including in the brains.